Identification, Characterization, and Insights into the Mechanism of Novel Dipeptidyl Peptidase-Iv Inhibitory Peptides from Yak Hemoglobin by in Silico Exploration, Molecular Docking, and in Vitro Assessment.
Jin Zhang,Yulong Wu,Honggang Tang,Huanhuan Li,Se Da,Dajie Ciren,Xinyan Peng,Ke Zhao
DOI: https://doi.org/10.1016/j.ijbiomac.2023.129191
IF: 8.2
2024-01-01
International Journal of Biological Macromolecules
Abstract:Dipeptidyl peptidase IV (DPP-IV) inhibitory peptides were screened and identified from yak hemoglobin for the first time by in silico analysis, molecular docking, and in vitro evaluation. Results showed that yak hemoglobin had a high potential to produce DPP-IV inhibitory peptides based on the sequence alignment and bioactive potential evaluation. Furthermore, "pancreatic elastase + stem bromelain" was the optimal combined-enzymatic strategy by simulated proteolysis. Additionally, 25 novel peptides were found from its simulated hydrolysate, among which 10 peptides had high binding affinities with DPP-IV by molecular docking. Most of these peptides were also in silico characterized with favorable physicochemical properties and biological potentials, including relatively low molecular weight, high hydrophobicity, several net charges, good water solubility, nontoxicity, acceptable sensory quality, and good human intestinal absorption. Finally, six novel DPP-IV inhibitory peptides were identified via in vitro assessment, among which EEKA (IC50 = 235.26 μM), DEV (IC50 = 339.45 μM), and HCDKL (IC50 = 632.93 μM) showed the strongest capacities. The hydrogen bonds and electrostatic attractions formed with core residues within the S2 pocket of DPP-IV could be mainly responsible for their inhibition performances. This work provided a time-saving method and broadened application for yak by-products development as sources of functional foods.